Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells by Gale, Zoe et al.
 
Glial cell line-derived neurotrophic factor induces proliferation of 
osteoblastic cells  
 
Zoe Gale, Paul R. Cooper, and Ben A. Scheven 
 
Cytokine 
Volume 57, Issue 2, Feb 2012, Pages 276-281 
ISSN 1043-4666 
 
DOI: 10.1016/j.cyto.2011.10.023 
 
 
This is the author’s post-print. The published version is available at 
http://www.sciencedirect.com/science/article/pii/S1043466611008143 
 
220 
 
 
Glial cell line-derived neurotrophic factor induces proliferation of  
osteoblastic cells 
 
 
 
Zoe Gale, Paul R. Cooper, and Ben A. Scheven 
 
School of Dentistry, College of Medical and Dental Sciences,  
University of Birmingham, Birmingham, U.K. 
 
ABSTRACT 
 
Little is known about the role of neurotrophic growth factors in bone metabolism. This 
study investigated the short-term effects of glial cell line-derived neurotrophic factor 
(GDNF) on calvarial-derived MC3T3-E1 osteoblasts. MC3T3-E1 expressed GDNF as 
well as its canonical receptors, GFR1 and RET. Addition of recombinant GDNF to 
cultures in serum-containing medium modestly inhibited cell growth at high 
concentrations; however, under serum-free culture conditions GDNF dose-dependently 
increased cell proliferation. GDNF effects on cell growth were inversely correlated with 
its effect on alkaline phosphatase (ALP) activity showing a significant dose-dependent 
inhibition of relative ALP activity with increasing concentrations of GDNF in serum-
free culture medium. Live/dead and lactate dehydrogenase assays demonstrated GDNF 
did not significantly affect cell death or survival under serum-containing and serum-free 
conditions. The effect of GDNF on cell growth was abolished in the presence of 
inhibitors to GFR1 and RET indicating that GDNF stimulated calvarial osteoblasts via 
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its canonical receptors. Finally, this study found that GDNF synergistically increased 
tumor necrosis factor-α (TNF-α)-stimulated MC3T3-E1 cell growth suggesting that 
GDNF interacted with TNF-α-induced signaling in osteoblastic cells. In conclusion, this 
study provides evidence for a direct, receptor-mediated effect of GDNF on osteoblasts 
highlighting a novel role for GDNF in bone physiology.    
 
 
 
Key words: GDNF, neurotrophic factor, TNF-alpha, osteoblast, bone, calvarial, cell 
proliferation 
 
 
 
1. Introduction 
 
Glial cell line-derived neurotrophic factor (GDNF) is a pleiotropic signaling molecule 
playing a pivotal role in the development and regulation of the nervous system (1-2). 
GDNF has been recognized as a potent survival factor for neuronal cells in addition to 
its essential roles in neural migration and differentiation (1-3).  GDNF is also widely 
expressed outside neuronal tissues and has been suggested to be involved in epithelial-
mesenchymal interactions during development of urogenital and dental tissues (1, 4-6). 
GDNF is able to elicit various intracellular signalling cascades via multiple receptor 
systems, primarily through the glycosyl-phosphatidylinositol-anchored, GDNF family 
receptor  (GFR1) and the tyrosine kinase transmembrane co-receptor RET (2-3).  
 
Neurotrophic growth factors and cytokines including GDNF have been shown to be 
expressed in bone marrow stromal cells prompting an emerging interest in therapeutic 
regenerative application of bone marrow-derived mesenchymal stem cells in 
neurological disorders (7-11). Interestingly, whilst GFR1 expression was detected 
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along with GDNF in bone marrow stromal cells, RET proved to be absent in these cells 
(12-13). However, GDNF/GFR1 complexes cleaved from the stromal cells were 
shown to elicit functional signaling through RET expressed on hematopoietic and 
leukemic cells suggesting a signaling pathway involving cell-cell interactions within the 
bone marrow environment  (13-14). In this study we addressed the question whether 
GDNF may be involved in bone metabolism. In particular, this study focused on the 
short term effects of GDNF on the proliferation and survival of osteoblastic cells using 
a non-transformed calvarial-derived cell line as model system for osteoblasts. In 
addition, the research investigated a possible interaction between GDNF and the 
multifunctional, pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α). 
 
2. Materials and methods 
 
2.1 Cell cultures  
 
The MC3T3-E1 cell line is a non-transformed, clonal osteoblast-like cell line 
established from mouse calvaria and has extensively been used as a physiologically 
relevant in vitro model for calvarial osteoblasts, osteogenic differentiation and bone 
formation (15).  MC3T3-E1 were acquired from the European Collection of Cell 
Cultures (ECACC) and were cultured in αMEM containing 10% Fetal Bovine Serum 
(FBS), 1% penicillin/streptomycin, 200 mM glutamine and 2.5 μg/ ml Amphotericin B 
(Sigma Aldrich, UK) in a humidified 5% CO2 incubator at 37
o 
C. Subconfluent cell 
cultures were trypsinised using Trypsin/EDTA (Gibco, UK) and plated into 96-
multiwell plates in MEM/10% FBS at 5,000 cells/well.  After 24 hours, the cultures 
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were replenished with either serum (10% FBS) or serum-free MEM supplemented 
with 0.1% bovine serum albumin (BSA). Recombinant human GDNF (rhGDNF, 
provided by Amgen, Thousand Oaks, USA) or TNF-α (PeproTech, UK) was added to 
the cultures for a further two days. For the receptor inhibitor experiments, cultures were 
treated for 1 hour with different concentrations of phosphoinositide phopsholipase C 
(PI-PLC; Sigma) which blocks signalling via GFRα1 (16), or RPI-1 
(Merck/Calbiochem), a specific RET receptor tyrosine kinase inhibitor (17), followed 
by further culture with the respective inhibitors in media with or without GDNF. 
 
2.2 Cell number and viability assays 
 
The WST1 assay (Roche Applied Biosciences) was used to assess the number of viable 
cells (18); the absorbance of the reduced compound was measured at a wavelength of 
450 with a reference filter at 630nm using a Biotek plate reader. The ―live/dead‖ assay 
used 4µM acridine orange to stain nuclei of live cells and 4µM ethidium bromide to 
label nuclei of dead cells. The number of live and dead cells per microscopic field was 
counted under a Nikon Eclipse fluorescent microscope using 480 and 520nm filters, 
respectively.  The level of cell death in the cultures was determined biochemically using 
a lactate dehydrogenase (LDH) cytotoxicity assay (Roche, UK). Cell culture 
supernatants were analysed after a 2-days’ culture for the presence of LDH. Absorbance 
was determined at 490/630nm using the Biotek plate reader.  
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2.3 BrdU cell proliferation assay 
Cell proliferation was assessed using a 5-bromo-2-deoxy-uridine (BrdU) labeling and 
detection kit (Roche Applied Sciences). In brief, cells were labeled with 10 μM BrdU 
for the final hour of the 48 hours’ culture followed by fixation and immunostaining for 
BrdU incorporation using a specific anti-BrdU antibody. Cells were counterstained with 
hematoxylin and the total number of labeled and non-labeled nuclei were counted in 50 
independent microscope fields. 
2.4 Biochemical alkaline phosphate (AlP) assay 
Cells were lysed in 0.1% Triton X-100 and incubated for 10 min in 1 M diethanolamine 
buffer (pH 9.8) containing 1mg/ml  p-nitrophenyl phosphate (pNPP)  at 37° C. 
Production of PNP (p-nitrophenol) was quantified spectrophotometrically at an 
absorbance of 405 nm using an automatic plate reader.  
 
2.5 Semi-quantitative RT-PCR (sqRT-PCR) analysis  
Cells were lysed in RLT buffer containing β-mercaptoethanol followed by RNA 
isolation using the RNeasy minikit (Qiagen, UK). Subsequently, 1μg of DNase-digested 
total RNA was used for oligo(dT) (Ambion, UK) reverse transcription to generate 
single-stranded cDNA using the Omniscript kit (Qiagen, UK). Centrifugal filters 
(Microcon) were used to purify and concentrate resultant cDNA.  Both RNA and cDNA 
concentrations were determined from absorbance values at a wavelength of 260 nm 
using a BioPhotometer (Eppendorf, UK). sqRT-PCR assays were performed using the 
RedTaq PCR system (Sigma, UK) and the Mastercycler gradient thermal cycler 
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(Eppendorf, UK). Primers were designed from NCBI mRNA sequences using Primer-3 
design software (Table 1).   
 
2.6 Immunocytochemistry 
 
MC3T3-E1 were seeded onto multispot microscope slides and incubated for 24h at 37 
0
C in a humidified 5% CO2 incubator (15,000 cells/well). The adherent cells were fixed 
with ice-cold acetone for 5 min followed by rinsing in phosphate-buffered saline (PBS) 
containing 1% BSA. Following incubation in 3% H2O2 for 30 min (to block endogenous 
peroxidase), the slides were washed in PBS and incubated in 20% normal goat serum 
followed by incubation with 2 µg/ml primary polygonal rabbit antibody against  GFRα1 
(sc10716, SantaCruz) or against RET (sc167; SantaCruz) overnight at 4
o 
C. Both 
antibodies have been shown to specifically recognise the respective protein receptors as 
determined by immunoblotting, and have been validated for use in 
immunocytochemical staining of cell membrane receptors (see manufacturer’s 
datasheets). To demonstrate that the immunocytochemical staining was specific for the 
primary antibody, the primary antibody was substituted with 20% normal rabbit serum. 
The slides were rinsed in PBS/1% BSA and labeled and stained with biotin-
streptavidin-HRP using a Biogenex detection kit (LP000-UL). The slides were 
counterstained with haematoxylin before examination under a Zeiss microscope.  
2.7 Data and statistical analysis 
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Data obtained from the WST-1, LDH and ALP assays were corrected for background 
values and expressed as percentage of controls. Data were analysed using ANOVA with 
Tukey’s posthoc test.    
 
 
3. Results 
 
 
3.1 Expression of GDNF, GFRα1 and RET in calvarial osteoblasts 
 
sqRT-PCR analysis revealed that GDNF and its receptors GFRα1 and RET were 
expressed in the osteoblast cell line MC3T3-E1 (Fig. 1A). No obvious changes in gene 
expression were evident in serum-free cultures as compared to cultures maintained in 
serum supplemented media (Fig. 1A). This observation was supported by gel image 
analysis (unpublished observations). Immunocytochemical staining of MC3T3-E1 using 
specific antibodies against GFRα1 and RET confirmed the presence of these GDNF 
receptors (Fig. 1B).  
 
3.2 GDNF stimulates MC3T3-E1 cell proliferation 
 
Addition of GDNF to the osteoblast-like cells did not elicit major changes in the 
number of viable cells over a 2-day culture period in medium supplemented with FBS; 
however, at 100 ng/ml GDNF a significant, albeit modest decrease in cell number was 
evident (82.9% of controls). Conversely, GDNF dose-dependently increased viable 
MC3T3-E1 numbers in serum-free cultures (Fig. 2A).    
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Biochemical analysis of alkaline phosphate (ALP), a non-specific marker for early 
osteoblast differentiation (19-20) demonstrated that GDNF had no significant effect on 
overall ALP activity (data not shown), but following correction for cell numbers a dose-
dependent decrease in ALP levels at increasing GDNF concentrations in serum-free 
cultures was evident (Fig. 2B). These data indicated that the reduced relative ALP 
activity in GDNF-treated serum-free cultures corresponded with increased cell growth.  
 
To corroborate the WST-1 data, cell proliferation was further analyzed using the BrdU-
incorporation assay. The BrdU data demonstrated that the mitotic activity in serum-free 
cultures was greatly reduced compared to the serum-supplemented cultures (Fig. 3). 
GDNF had a modest, albeit non-significant, effect on BrdU labeling in serum-
containing cultures (23% reduction compared to controls). However, GDNF 
significantly increased the number of BrdU-labeled cells in serum-free cultures by 
103.7% (i.e. two-fold increase) demonstrating that GDNF stimulated cell replication 
under these conditions (Fig. 3).  
 
3.3 GDNF does not affect osteoblast cell survival 
 
To further investigate whether GDNF influenced cell survival, the live-dead assay was 
applied. Results demonstrated that significant cell death occurred in control, serum-free 
cultures as compared to serum-supplemented cultures (Fig. 4A). GDNF did not 
significantly affect the number of dead cells in either serum-containing or serum-free 
cultures suggesting that GDNF did not affect cell death or survival under either 
condition (Fig. 4A).  
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These data were corroborated by the biochemical cytotoxicity LDH assay demonstrating 
that GDNF did not influence the level of cell death under serum-free conditions (Fig. 
4B).  
 
3.4 Receptor-mediated effects of GDNF   
 
To determine whether GDNF affected the cells through its canonical receptors GFRα1 
and RET, cultures were treated with specific compounds known to block GDNF 
signalling. PI-PLC which hydrolyses the GFRα1 subunits from their 
glycosylphosphatidylinositol (GPI)-anchored membrane proteins thereby negating 
GDNF signalling via this receptor, abrogated GDNF effects on viable cell numbers in 
serum-free cultures (Fig. 5).  These data underline an essential role for GFRα1 in the 
GDNF effects on osteoblast viability. RPI-1, a competitive ATP-dependent RET kinase 
inhibitor, dose-dependently blocked GDNF action indicating that activation of the RET 
co-receptor was necessary to elicit GDNF signalling in these cells (Fig. 5).  
 
3.4 Interaction of GDNF with TNFα 
 
Finally this study investigated the effects of GDNF in the presence of the pro-
inflammatory cytokine TNF-α, which is known to have profound effects on bone cells 
including MC3T3-E1 osteoblastic cells (21-23). TNF-α dose-dependently increased 
viable cell numbers in both serum-containing and serum-free MC3T3-E1 cultures (Fig. 
6). Addition of GDNF to the cultures supplemented with TNF-α further promoted 
osteoblastic cell growth in these cultures: The stimulating effects of GDNF appeared 
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relatively modest and non-significant in the 10% FBS cultures (Fig. 6A); however, 
GDNF synergistically increased cell numbers in the presence of TNF-α in serum-free 
cultures (Fig. 6B).  
 
4 Discussion  
 
The current study provides evidence of a direct effect of GDNF on calvarial-derived 
osteoblasts suggesting a potential role for this neurotrophic factor in the regulation of 
craniofacial bone metabolism. GDNF as well as both of its canonical receptors GFRα1 
and RET were shown to be expressed in MC3T3-E1 osteoblastic cells and signaling 
through both receptors was needed for GDNF effects on osteoblast cell growth. This is a 
novel and interesting finding, as previous studies reported that only GDNF and 
GFRα1were present in two human osteosarcoma cell lines (Saos-2, MG63) and primary 
bone marrow stromal cells, but not RET (12). Thus this latter work had led to the 
conclusion that GDNF signaling in the bone marrow environment involved interaction 
with RET-expressing hematopoietic cells (13-14). Previous studies have suggested that 
isolated cells from calvarial bones may behave differently than osteoblasts derived from 
long bones ((21-23)), which may reflect the mechanistically different processes by 
which the different structures in the skeleton develop (i.e. flat bones via 
intramembranous bone formation, whereas long bones through the process of 
endochondral bone formation; (27)). Moreover, it is worth noting that a significant part 
of the craniofacial skeleton originates from neuronal crest ―ecto-mesenchymal‖ 
progenitor cells and therefore the calvarial osteoblasts may therefore exhibit a different 
molecular repertoire and cell behavior than mesodermal/mesenchymal-derived bone-
forming cells present in long bones (24-26). RET is considered important for 
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development and differentiation of neural crest-derived tissues, including cranial tissues 
(28-30). GDNF was shown to be co-expressed with GFRα1/2 and RET in dental 
epithelial and mesenchymal cells during tooth development (31,32). Our recent studies 
indicated that mesenchymal/stromal cell cultures derived from dental pulp also 
displayed co-expression of GDNF and GFRα1/RET (33). RT-PCR analysis suggested 
that the calvarial osteoblasts expressed GDNF and the receptors GFRα1 and RET in 
serum-free cultures to a similar degree as cells maintained in serum-supplemented 
media.Previous studies demonstrated gene expression of both GDNF receptor 
components GFRα1 and RET in adrenal medullary cells and glial cells cultured in 
serum-free medium (34, 35).Interestingly, addition of serum upregulated the 
transcription levels of GFRα1 and RET in these cells (34, 35). Further quantitative RT-
PCR is recommended to evaluate and substantiate the effects of culture conditions on 
gene expression in osteoblasts; notwithstanding our observations indicate that the 
calvarial osteoblastic cell line expressing the primary GDNF receptors represents a 
suitable model to investigate GDNF signaling in either serum-containing or serum-free 
culture media.  
This study demonstrates that GDNF stimulated MC3T3-E1 cell proliferation in 
serum-free conditions, which corresponded with a concomitant inhibitory effect on 
relative ALP activity, a marker of early osteogenic differentiation. Moreover, our data 
indicate that GDNF at high concentrations exerted a cell growth curbing effect on 
osteoblasts maintained in serum-supplemented culture medium; an effect that appeared 
to be associated with a slight increase in ALP activity (Fig. 2). It is well established that 
cell differentiation is often inversely related with mitotic activity and our observations 
indicate that GDNF effect on calvarial osteoblasts mainly involves an action on cellular 
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proliferation with a concomitant inverse effect on immediate differentiation. 
Interestingly, GDNF/RET signaling has been shown to be responsible for the anti-
mitotic action in an embryonic neural precursor carcinoma cell line (36). This effect 
mediated by p27
kip1
 was suggested to be a mechanism by which GDNF regulates cell 
growth to initiate terminal differentiation (36). Long-term culture experiments will be 
required to investigate in further detail the role of GDNF in osteogenic proliferation, 
differentiation and bone formation.  
 
The mitotic and cell survival actions of GDNF through GFRα1/RET signaling 
are well documented in the literature underscoring the multifunctional role of GDNF in 
tissue maintenance, repair and regeneration (1-3). Shi et al (37) described that GDNF 
promoted mesenchymal stem cell migration and survival; a mechanism by which GDNF 
may deliver renoprotection and kidney repair. The physiological implications of our 
findings that GDNF stimulated calvarial osteoblast proliferation under serum-deprived 
conditions are as yet unclear, but may allude to a novel role of this neurotrophic factor 
in bone remodeling and repair. GDNF is considered a member of the TGFβ superfamily 
as it has a partial amino-acid sequence homology and similar structural confirmation to 
TGF (38), which comprise growth factors including bone morphogenetic proteins 
pivotal in regulation of bone development, metabolism and repair. TGF1 can have 
diverse and multiple effects in different cell systems; notably this signaling molecule 
has been ascribed a central role in bone cell recruitment, proliferation and 
differentiation (39). Interestingly, TGF1 induces translocation of GFR1 to the plasma 
membrane thereby enabling GDNF signaling through this receptor (40). It is also worth 
noting that GDNF is a potent inducer of the nuclear transcription factor, murine GDNF 
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inducible factor (mGIF) which is homologous to the human TGFβ inducible early gene 
(TIEG) (41). TIEG expression which has been suggested to play a pivotal role  in the 
regulation of osteoblast differentiation (42) is highly induced in human osteosarcoma 
cells as well as immortalized human fetal osteoblasts following treatment with TGFβ 
(43).  It would be fascinating to explore whether GDNF signaling in calvarial 
osteoblasts is related to induction of TIEG/mGIF. 
Considering that GDNF is produced by bone marrow stromal cells as well as 
osteoblasts (9, 44, 45), it is tempting to speculate that GDNF in conjunction with other 
auto- and paracrine factors may be involved in the regulation of osteoblast recruitment 
in bone growth and remodelling. Indeed, this study demonstrated that GDNF cooperated 
with the cytokine TNF-α to stimulate osteoblastic cell growth suggesting an interaction 
between GDNF and TNF-α signalling pathways in osteoblasts. TNF-α has been ascribed 
a multifunctional role in bone metabolism (22); TNF-α effects may involve a pro-
resorptive (osteoclastic bone degradation) action during inflammatory conditions (21), 
but TNF-α has also been recognised as an anabolic cytokine stimulating osteogenic 
migration, proliferation and differentiation  (46-50). Interestingly, TNF-α has been 
shown to have neuroprotective capabilities which in part may be dependent on 
induction of cytoprotective neutrotrophic growth factors such as GDNF (51-53).  
Moreover TNF-α was reported to induce GDNF in chondrocytes underscoring a 
potential role for GDNF in skeletal cells under pro-inflammatory conditions (54). 
Further research is warranted to explore the precise role and mechanistic interaction of 
these pleiotrophic signaling molecules in bone remodeling and their potential 
therapeutic use in bone regeneration and repair.       
 
233 
 
In conclusion, this is the first study to report that the neurotrophic factor GDNF 
is able to influence the proliferation of calvarial osteoblasts via its canonical receptors 
GFRα/RET expressed on these cells highlighting a novel regulatory pathway in 
craniofacial bone physiology.  
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Tables and figures 
 
 
Table 1.  PCR primer sequences and annealing temperature (Tm) 
 
Gene 
symbol 
Primer sequence (5’ to 3’) Genbank 
Accession no. 
Product 
size 
Tm 
GAPDH F-CCCATCACCATCTTCCAGGAGC  
R-CCAGTGAGCTTCCCGTTCAGC 
NM017008 450bp 60 
GDNF F-AGAGGAATCGGCAGGCTGCAGCTG  
R-AGATACATCCACATCGTTTAGCGG 
NM019139 337bp 60 
RET  
 
F-TCAGGCATTTTGCAGCTATG 
R-TGCAAAGGATGTGAAAGCAG 
NM001110099 393bp 62.5 
GFRα1 F-AATGCAATTCAAGCCTTTGG  
R-TGTGTGCTACCCGACACATT 
U59486 218bp 60 
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Fig. 1. (A) Representative RT-PCR gel images demonstrating the presence of 
transcripts for GDNF and its receptors GFRa1 and RET in MC3T3-E1 calvarial 
osteoblasts cultured 
in serum-supplemented (10% FBS) or serum-free culture medium for 2 days. C6 glioma 
cells were used as positive control, and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) as control, housekeeping gene. Respective cycle number used for GDNF, 
GFRa1, RET and GAPDH were 35, 45, 45 and 25. (B) Immunocytochemical staining of 
MC3T3-E1 for GFRa1 and RET. Positive staining (brown) for both receptors was 
clearly evident in the MC3T3-E1 cells, whilst immunostaining was absent in controls 
(specific 
primary antibody was substituted with non-immune rabbit serum). (For interpretation of 
the references to colour in this figure legend, the reader is referred to the web 
version of this article.)       
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Fig. 2. (A) Effect of GDNF on viable MC3T3-E1 cell number in 2-day serum 
supplemented 
(10% FBS) or serum-free (0.1% BSA) cultures as assessed by WST-1. 
Results are expressed as percentage of controls (mean ± SD; n = 4). (B) Effect of 
GDNF on alkaline phosphatase (AlP) activity in osteoblast cultures after 2 days of 
culture. Results represent relative AlP activity corrected for cell number (percentage 
of controls; mean ± SD; n = 4). ⁄P < 0.05, ⁄⁄P < 0.01 versus control values. 
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Fig. 3. BrdU incorporation in 2-day MC3T3-E1 cultures in serum-supplemented 
(10% FBS) or serum-free (0.1% BSA) cultures. The results show the proportion of 
cells labeled positively for BrdU (Li: labeling index). Significantly different from 
controls: ⁄P < 0.05. 
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Fig. 4. Effects of GDNF on cell death in MC3T3-E1 cultures. (A) The number of dead 
cells as determined by the live/dead assay in cultures treated with 100 ng/ml GDNF. 
Results show percentage of dead cells in 1- and 2-day cultures (mean ± SD; n = 3). 
(B) Relative LDH levels after 2-days culture in serum-containing or serum-free 
medium cultures supplemented with 100 ng/ml GDNF (mean ± SD; n = 3). Results 
are mean ± SD (n = 3–4). 
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Fig. 5. Effects of GDNF receptor inhibitors on GDNF-stimulated MC3T3-E1 cultures. 
(A) Effect of phosphatidylinositol-specific phospholipase C (PLC) on viable cell 
number in cultures supplemented with 100 ng/ml GDNF. (B) Effects of the RET 
kinase inhibitor, RPI-1, on viable cell number in 2-day GDNF-treated cell cultures. 
Results are percentage of control values as determined by the WST1 assay 
(mean} SD of 6.8 replicates). Data from GDNF control cultures (without inhibitor) 
were significantly different from controls without GDNF (P < 0.01). ..P < 0.01 versus 
GDNF cultures. 
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Fig. 6. Osteoblastic MC3T3-E1 cell numbers after 2-days’ culture in the presence of 
increasing concentrations of TNF-a with or without 100 ng/ml GDNF in media 
supplemented with 10% serum (A) or in serum-free cultures (B).Viable cell numbers 
were assessed using the WST-1 assay; results are expressed as percentage of 
controls (mean ± SEM; n = 3). ⁄P < 0.05, ⁄⁄⁄P < 0.001 GDNF-supplemented cultures 
versus corresponding TNF-a controls. 
 
 
